Article Text

Download PDFPDF

The isolated caecal patch lesion: a clinical, endoscopic and histopathological study
  1. Anju Ekanayaka1,
  2. John T Anderson2,
  3. Michele E Lucarotti3,
  4. Roland M Valori4,
  5. Neil A Shepherd1
  1. 1 Gloucestershire Cellular Pathology Laboratory, Cheltenham, UK
  2. 2 Department of Gastroenterology, Cheltenham General Hospital, Cheltenham, UK
  3. 3 Department of Colorectal Surgery, Gloucestershire Royal Hospital, Gloucester, UK
  4. 4 Department of Gastroenterology, Gloucestershire Royal Hospital, Gloucester, UK
  1. Correspondence to Professor Neil A Shepherd, Gloucestershire Cellular Pathology Laboratory, Cheltenham General Hospital, Sandford Road, Cheltenham, Gloucester GL53 7AN, UK; neil.a.shepherd{at}


Objective To describe and investigate the potential causes of the isolated caecal patch lesion, a previously undescribed endoscopic phenomenon of a lesion fulfilling endoscopic and histopathological criteria for chronic inflammatory bowel disease but without evidence of similar inflammatory pathology elsewhere at colonoscopy.

Methods Cases were collected prospectively by one specialist gastrointestinal pathologist over a 10-year period. Full endoscopic and histopathological analysis was undertaken and follow-up sought to understand the likely cause(s) of the lesions.

Results Six cases are described. Two had very close links with ulcerative colitis, one predating the onset of classical distal disease and the other occurring after previous demonstration of classical distal ulcerative colitis. Two occurred in younger patients and we postulate that these lesions may predict the subsequent onset of chronic inflammatory bowel disease. Finally two can be reasonably attributed to the effects of non-steroidal inflammatory agent therapy.

Conclusions Caecal patch lesions can be demonstrated in isolation. Despite the strong association of caecal patch lesions with ulcerative colitis, solitary lesions may well have disparate causes but nevertheless possess a close relationship with chronic inflammatory bowel disease.

  • inflammatory bowel disease
  • intestine
  • colon
  • gastrointestinal disease
  • histopathology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Various clinical, endoscopic and pathological features are used to differentiate ulcerative colitis (UC) from its main differential diagnosis, Crohn’s disease. Continuity of disease, especially in the colon, is one of the most important, discontinuity of disease being a key feature of intestinal Crohn’s disease.1 2 UC is characteristically a continuous disease, involving the rectum and a variable extent of the colon. Despite this, it is now recognised that UC itself can be discontinuous. There may be continuous disease in the rectum and distal colon, a normal proximal colon and involvement of the appendix, a situation that has been termed ‘the appendiceal skip lesion of UC’.3 4 We also recognise a close relationship between diverticular disease and UC. ‘Diverticular colitis’ may represent discontinuous UC afflicting the sigmoid colon and there are now many established cases where diverticular colitis, with the luminal mucosa of the sigmoid colon showing characteristic histopathological features of chronic inflammatory bowel disease (CIBD), but with an entirely normal rectal mucosal pathology, has preceded the subsequent onset of classical UC with involvement of the rectal mucosa by chronic active inflammation and the distinctive features of UC.5 6

The link to discontinuous colonic involvement in chronic UC is now recognised with both appendiceal involvement and the ‘caecal patch lesion’.7–11 Similar to the appendiceal skip lesion of UC, there is continuous distal disease of UC, with more proximal colonic normality and then an isolated focus of caecal involvement by chronic active inflammatory disease, producing the caecal patch lesion. This has identical histological appearances to those seen in the more distal colon and rectum with the characteristic changes of active CIBD.7 11 12

The caecal patch lesion was first defined in 1958 by Lumb and Protheroe, who described eight cases in which the features of UC occurred as ‘an island’ within normal caecal mucosa, with a tendency to occur in the lower caecum opposite the ileocaecal valve.12 Since that initial description, there have been several other reports, case series, reviews and studies published to elucidate the prevalence and significance of caecal patch lesions in UC.7–9 11 13–16 Caecal patch lesions indicate the likelihood of more severe distal disease although the lesion itself is associated with a better response to therapy.13 They are more common in younger male patients with UC and associated with more pronounced symptomatology, especially abdominal pain, rectal bleeding and diarrhoea.11 14 In contrast, the presence of appendiceal orifice inflammation does not predict the prognosis of UC, including remission rate, relapse rate, proximal disease extension and the need for proctocolectomy.15 16

This paper describes our experience with the ‘isolated caecal patch lesion’ (ICPL), where the caecal lesion, as defined, is the only significant finding at colonoscopy. To our knowledge, this phenomenon has not been recognised in the literature. Because of this, it is appropriate that this phenomenon is rigorously defined. By the ICPL, we infer a variable clinical presentation and an endoscopic appearance of an isolated and localised area of inflamed mucosa contained within the caecum, with histopathological features in keeping with CIBD. The latter includes diffuse chronic inflammation of the lamina propria, active inflammation, whether intraepithelial polymorphs and/or established crypt abscesses, evidence of crypt architectural distortion, mucin depletion, however variable, and no evidence of granulomatous pathology. Those histopathological features are, of course, suggestive of UC but, as part of the definition, we imply that the remaining colonoscopy shows no other features to suggest CIBD elsewhere (any incidental pathology would still be acceptable) and knowledge that biopsies taken elsewhere in the colon and rectum, especially the rectum, show no evidence of CIBD. Further, in none of our cases was there any evidence, at the time of the relevant colonoscopy, whether clinical, radiological, endoscopic or histological, to suggest CIBD elsewhere in the gastrointestinal tract, especially, of course, in the terminal ileum and rectum.

Materials and methods

The six cases described here represent a retrospective series from the files of one specialist gastrointestinal pathologist (NAS). All patients derive from our two hospitals in Gloucestershire and were collected during a 10-year period from 2006 to 2016. The patients included in this study had a diagnosis of ICPL, demonstrated endoscopically and confirmed histologically as previously defined. Endoscopically all patients had a patch of disease typified by erythema, loss of vascular pattern and granularity of the mucosa identical to that usually seen in UC in the distal colon and rectum. The lesion was usually symmetrical around the appendix orifice extending 1–5 cm distally with a relatively sharp cut-off to normal-appearing mucosa. In none of our patients did the lesion extend beyond the caecal pole. The remaining colon and rectum were either normal or harboured incidental pathology not relevant to CIBD. Biopsies taken from the caecal patch lesion showed the pathological features of active CIBD and all other colonoscopic biopsies showed no histological evidence of CIBD.

Baseline data, including gender, age at diagnosis, initial symptoms/indication and endoscopic details were extracted by reviewing the medical records of the patients. These medical records were reviewed for additional relevant details including drug history, any treatment of the presenting symptoms, the response to that treatment, subsequent symptoms and follow-up endoscopy. After data collection, identifying medical record numbers and names were removed, and unique identifiers were created to ensure patient confidentiality.

All histopathological materials, from the intestines of all patients, were reviewed. The inflammatory changes present in the caecal biopsies were scored according to the activity index developed by Geboes and his colleagues.17


The clinical and endoscopic details are presented in table 1. The patients’ ages ranged from 28 to 57, three women and three men. Four patients presented with chronic diarrhoea; in three of them, there was also per-rectal (PR) bleeding. One patient had had one episode of fresh PR bleeding only. One presented with chronic abdominal pain. One patient had a strong family history of UC: the mother and grandmother had had UC. Two patients had a history of non-steroidal inflammatory agents’ (NSAIDs) usage.

Table 1

Clinical and endoscopic data

Endoscopic findings

All patients had isolated inflammatory changes confined to the caecum. The lesions were easily distinguishable from the surrounding mucosa. Optical evaluation revealed a discrete spherical or oval-shaped area with diffuse hyperaemia (figure 1). Individual cases exhibited varying degrees of endoscopically visible erythema. Within this background change, there were discrete white punctate patches which may or may not have coalesced. The involved area was friable and demonstrated either contact bleeding, with minimal trauma, or profound oozing after biopsy. The endoscopic features had the appearance of superficial erosive or microulcerative change. The mucosa was minimally nodular in appearance and not raised compared with the surrounding mucosa. Although the lesions were well localised, the margins were not well circumscribed. The erythematous areas blended with the adjacent normal mucosa. Narrow band imaging revealed dark areas, reflecting the increased vascularity and inflammation present (figure 2). Incidental findings, at colonoscopy, included uncomplicated diverticular disease in one patient and one small polyp in the transverse colon in another. The remaining colonoscopy was normal in all the other patients.

Figure 1

The isolated caecal patch lesion at endoscopy in patient 1. There is a discrete oval-shaped area with diffuse hyperaemia and white punctate patches, some coalescent, within.

Figure 2

A narrow band image of the isolated caecal patch lesion in figure 1. The dark areas represent the increased vascularity due to the inflammation present.

Histological findings

The histological features are summarised in table 2. Architectural abnormalities, in the form of crypt architectural changes, and acute and chronic inflammation were identified in all biopsies taken from the caecum (figure 3). The histological appearances very much reflected the endoscopic appearances. All the cases showed similar features with remarkably similar levels of active inflammation (table 2). All patients showed no evidence of active inflammation/CIBD at any site apart from the caecum at the relevant colonoscopy.

Figure 3

A biopsy from the isolated caecal patch lesion in the caecum of patient 2. At this power, the crypt architectural distortion and diffuse chronic inflammation are obvious. There was more patchy active inflammation. The features are very similar to those seen in ulcerative colitis.

Table 2

Grading of histological variables (after Geboes et al 17)

Follow-up findings and associations

The follow-up details are presented in table 3. Two patients showed very clear associations with CIBD. Patient 1, with no previous history and only a caecal patch lesion at the index colonoscopy, re-presented 6 months later with classical UC, in a proctitis distribution, when the caecal patch lesion was also present. Patient 2 had previously documented UC, in a ‘distal colitis’ distribution, 5 years previously. This was treated and the patient was in remission until the diagnosis of isolated caecal patch was made, after she had represented with chronic diarrhoea. At that time, there was only endoscopic evidence of a caecal patch lesion with no evidence of UC elsewhere despite extensive biopsies of the colon and rectum.

Table 3

Patient follow-up details

Two younger patients, aged 21 and 28 (patients 3 and 4), were effectively treated for CIBD and remain symptomatically free of disease 3 years and 5 years after the diagnoses of ICPLs, respectively. It may be that the presentation with ICPLs is a prelude to the subsequent development of UC but, at the current time, there is no positive evidence of this.

Finally, two patients had been on NSAID therapy. Patients 5 and 6 had both been taking diclofenac (voltarol) for 2 years because of osteoarthritis. There was no significant drug history for the other four patients. NSAIDs are a well-recognised cause of inflammatory pathology in the intestines and a cause of mimicry of CIBD. In both patients, the NSAIDs were stopped with no clinical or endoscopic evidence of disease in the intestines subsequently. We believe the NSAIDs are the likely cause of the caecal patch lesions in these two patients.


This study has demonstrated that classical caecal patch lesions can be seen in isolation at colonoscopy. Here we describe six such cases and provide evidence that they represent a disparate group, in terms of causation. Two cases show features demonstrating a strong relationship with UC. One patient presented with an ICPL but subsequently re-presented with classical UC in a ‘proctitis’ distribution. This is similar to the now well-documented occurrence of patients with isolated diverticular colitis re-presenting subsequently with classical UC, despite there being no evidence of the latter diagnosis at the index endoscopy.5 6 Perhaps it is no surprise that, in one case, ICPL occurred in a patient already known to have had UC previously. We recognise that UC can return to effective normality, both endoscopically18 19 and histopathologically20 but this study is the first to identify that recrudescent disease can be solely with an ICPL.

Two cases have occurred in younger patients and we postulate that these patients may eventually re-present with classical UC, the ICPLs perhaps being the harbinger of more classical UC disease although some may regard that as speculative. Those patients had no other significant history and, in particular, no relevant drug history.

NSAIDs are implicated in a wide range of gastrointestinal pathology.21 In the upper gastrointestinal tract, they are an important cause of gastritis, duodenitis and peptic ulceration.21 22 In the small intestine, long-term inflammation can result in stricturing and ‘diaphragm disease’.23 Diaphragm disease due to NSAIDs has also been seen in the proximal colon and NSAIDs have also been found responsible for inducing acute appendicitis and acute diverticulitis in patients with sigmoid colonic diverticular disease.21 NSAIDs also have a close relationship with CIBD.24 25 They are recognised to induce relapses of UC,24 25 and some have postulated that they may even cause CIBD.26 Mimicry of CIBD by NSAID enterocolopathy is well described.27 28 It is apposite therefore that two of our patients had been on long-term diclofenac, an NSAID agent well recognised to cause gastrointestinal pathology.29 The fact that both patients are in clinical remission from gastrointestinal symptoms after discontinuing diclofenac implies that NSAIDs may well be the cause of the ICPL in these patients although it is impossible to exclude other potential aetiologies. Indeed, even in these patients, the ICPLs may be a harbinger for the development of subsequent CIBD.

The pathogenesis of ICPLs, when they occur in association with classical UC, remains uncertain. What is notable is that these lesions occur at sites of relative faecal stasis. The same argument can be applied to the appendiceal ‘skip lesion of UC’ whereby active inflammation is notably confined to the mucosa of the appendix, in the absence of active inflammation elsewhere in the proximal large intestine, but with classical UC more distally. Indeed the link with faecal stasis can also be implied to explain the association of diverticular colitis with UC, especially those cases that present initially with diverticular colitis and then go on to present with classical UC.5 6 In those cases, the initial inflammatory pathology occurs at sites of considerable faecal stasis, sigmoid colonic diverticula. Furthermore, we recognise that the most common site for UC, especially at the index presentation, is the rectum, another site that is clearly associated with faecal stasis. Could faecal stasis, then, be an important pathogenetic factor in the development of these ‘skip lesions’ of UC and, ultimately, in the causation of UC itself? There has been a considerable body of work researching the relationship between faecal stasis and mucolysis and there has also been much research on the influence of mucin pathology in the genesis of UC.30–32 Do these cases, wherein isolated disease occurs at sites of faecal stasis, provide support for these theories about the aetiopathogenesis of chronic UC?

This study has introduced a novel endoscopic and pathological phenomenon, the ICPL, and has provided evidence to suggest potential causes in the six cases. There is no doubt that the lesion has a close relationship with chronic UC. In none of our cases was there any clinical, endoscopic or, especially, pathological evidence of Crohn’s disease but Crohn’s disease remains a possible, if unlikely, cause of the endoscopic finding of ICPL. We postulate that NSAIDs are an occasional cause of these lesions. The ICPL highlights the interesting occurrence of UC at sites of faecal stasis and hints at a potential pathogenetic factor in the development of chronic UC.

Take home messages

  • Caecal patch lesions are an increasingly recognised feature of chronic ulcerative colitis.

  • Caecal patch lesions show characteristic endoscopic and histological features.

  • Caecal patch lesions may predate the onset of classical distal ulcerative colitis.

  • Caecal patch lesions may be caused by diseases other than ulcerative colitis.



  • Handling editor Dhirendra Govender.

  • Contributors NAS collected the initial data. AE collected and organised the data on the pathological findings and AE and NAS assessed the pathology equally and contributed to the writing and editing of the manuscript equally. JTA, MEL and RMV all contributed equally to the collection and organisation of clinical and endoscopic data and the writing and editing of the manuscript. JTA provided the endoscopic photographs.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available on reasonable request.